43 investors focused on Biotech targeting China

Compare 43 investors focused on Biotech targeting China. Review the selection, investor types and reported focus with 2080 Ventures.

By 2080 Ventures · Updated September 21, 2026

43matching investors

3individual investors

40organizations

What this selection covers

This guide contains 43 distinct directory identities matching target markets: China; sectors: Biotech. Counts describe Investor Atlas coverage, not the size of the market or currently available capital.

“Targeting China” means the source explicitly lists this investment market. These investors may be headquartered elsewhere. Worldwide or regional labels are not expanded into individual countries.

Investor types represented: Venture Capital (33), Corporate Venture Capital (7), Private Equity (5), Angel Investor (3).

Prepare a focused approach

Explain the development pathway, validation milestones and capital needed to reach the next evidence point.

Before pitching for China, confirm incorporation requirements, team location and whether the mandate supports market entry or only established local operations.

Check the current mandate and recent investments.
Confirm check size, lead or follow preference, and company eligibility.
Identify the relevant partner and published pitch route.
Explain your customer evidence, raise and specific reason for approaching this investor.

Explore the 43 matching investors

Listed alphabetically, without ranking by performance or likelihood of investment. Full profiles, investment criteria and available contact details require sign-in.

Investor	Investor type	Research
AIAisling Capital	Private Equity	View profile ↗
ANAndreessen Horowitz	Venture Capital	View profile ↗
ANAntler	Venture Capital	View profile ↗
ARArdian	Private Equity	View profile ↗
ATAtlas Venture	Venture Capital	View profile ↗
BABain Capital	Venture Capital	View profile ↗
BABain Capital Ventures	Venture Capital, Corporate Venture Capital	View profile ↗
BOBoehringer Ingelheim Venture Fund	Venture Capital, Corporate Venture Capital	View profile ↗
BPBP Ventures	Venture Capital, Corporate Venture Capital	View profile ↗
CHChengwei Capital	Venture Capital	View profile ↗
CHCherubic Ventures	Venture Capital	View profile ↗
CHChina Baoan Group	Venture Capital	View profile ↗
EXEXPERT DOJO	Venture Capital, Accelerator	View profile ↗
FLFlagship Pioneering	Venture Capital	View profile ↗
FLFlashpoint VC	Venture Capital	View profile ↗
GEGeneral Atlantic	Venture Capital	View profile ↗
GLGlobal Founders Capital	Venture Capital, Family Office	View profile ↗
GOGobi Partners	Venture Capital	View profile ↗
GRGranite Asia	Venture Capital	View profile ↗
GRGreat Eagle Holdings	Corporate Venture Capital	View profile ↗
HBHBM Partners	Private Equity	View profile ↗
HEHemi Ventures	Venture Capital	View profile ↗
HUHumboldt Fund	Venture Capital	View profile ↗
IGiGlobe Partners	Venture Capital	View profile ↗
INIndex Ventures	Venture Capital	View profile ↗
INIndieBio	Venture Capital	View profile ↗
ININNO-APAC	Accelerator	View profile ↗
KHKhosla Ventures	Venture Capital	View profile ↗
LBLB Investment	Private Equity	View profile ↗
LILightstone Ventures	Venture Capital	View profile ↗
LULuka Novak	Angel Investor	View profile ↗
MAMatt Sutherland	Angel Investor	View profile ↗
MIMichael Wieser	Angel Investor	View profile ↗
MPMPM Capital	Venture Capital	View profile ↗
NONovartis Venture Fund	Venture Capital, Corporate Venture Capital	View profile ↗
NONovo Holdings	Venture Capital, Corporate Venture Capital	View profile ↗
OROrbiMed	Private Equity	View profile ↗
PFPfizer Venture Investments	Venture Capital, Corporate Venture Capital	View profile ↗
PIPivotal bioVenture Partners	Venture Capital	View profile ↗
SHShenzhen Capital Group	Venture Capital	View profile ↗
SHSherpa Venture Capital	Venture Capital	View profile ↗
VEVenrock	Venture Capital	View profile ↗
VEVersant Ventures	Venture Capital	View profile ↗